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Abstract
GATA4 is an essential transcription factor required for the development and function of multiple tissues, including a major
role in gonadogenesis. Despite its crucial role, the molecular mechanisms that regulate Gata4 expression in vivo remain
poorly understood. We recently found that the Gata4 gene is expressed as multiple transcripts with distinct 59 origins. These
co-expressed alternative transcripts are generated by different non-coding first exons with transcripts E1a and E1b being
the most prominent. Moreover, we previously showed that an Ebox element, located in Gata4 59 flanking sequences
upstream of exon 1a, is important for the promoter activity of these sequences in cell lines. To confirm the importance of
this element in vivo, we generated and characterized Gata4 Ebox knockout mice. Quantitative PCR analyses realized on
gonads, heart and liver at three developmental stages (embryonic, pre-pubertal and adult) revealed that the Ebox mutation
leads to a robust and specific decrease (up to 89%) of Gata4 E1a transcript expression in all tissues and stages examined.
However, a detailed characterization of the gonads revealed normal morphology and GATA4 protein levels in these
mutants. Our qPCR data further indicate that this outcome is most likely due to the presence of Gata4 E1b mRNA, whose
expression levels were not decreased by the Ebox mutation. In conclusion, our work clearly confirms the importance of the
proximal Ebox element and suggests that adequate GATA4 protein expression is likely protected by a compensation
mechanism between Gata4 E1a and E1b transcripts operating at the translational level.
Citation: Boulende Sab A, Bouchard M-F, Be ´land M, Prud’homme B, Souchkova O, et al. (2011) An Ebox Element in the Proximal Gata4 Promoter Is Required for
Gata4 Expression In Vivo. PLoS ONE 6(12): e29038. doi:10.1371/journal.pone.0029038
Editor: Pierre-Antoine Defossez, Universite ´ Paris-Diderot, France
Received September 27, 2011; Accepted November 19, 2011; Published December 13, 2011
Copyright:  2011 Boulende Sab et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: ABS is supported by a (Universite a du Quebec a Montreal) UQAM scholarship, RSV holds the Canada Research Chair in Reproduction and Sex
Development and NP is a Fonds de Recherche Sante (FRSQ) Jr1 Scholar. This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP-
14796 to RSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pilon.nicolas@uqam.ca (NP); robert.viger@crchul.ulaval.ca (RSV)
Introduction
GATA family members (GATA1 to 6) are conserved among
many species and display distinctive but overlapping spatio-
temporal expression patterns [1,2]. These proteins share a highly
homologous zinc finger DNA binding domain and bind to a
common consensus sequence motif (A/T)GATA(A/G) found in
the promoter region of numerous genes. GATA members are
subdivided in GATA1/2/3 and GATA4/5/6 subgroups.
GATA1/2/3 factors are mostly but not exclusively involved in
specification of hematopoietic lineages whereas GATA4/5/6
factors are involved in the development of mesodermal and
endodermal-derived tissues, such as heart, gut, liver and gonads
[2].
In the mouse, Gata4 is known as the sole Gata gene expressed in
somatic cells of the genital ridges around the time of sex
determination at e10.5–11.5 [3,4]. Strong Gata4 expression then
persists throughout male development and is maintained in adult
Sertoli and Leydig cells. In the female, Gata4 expression is slightly
downregulated following sex determination but Gata4 expression
persists in postnatal and adult granulosa and thecal cells [3].
Although a number of GATA4 targets have first been identified
via promoter studies in gonadal cell lines, a detailled analysis of the
gonadal function of GATA4 in vivo has long been hampered by the
early embryonic lethality of Gata4-null embryos at e9.5 [5,6,7].
This situation prompted the development of genetically-modified
mouse models that circumvent early embryonic lethality and now
provide clear evidence for a crucial and complex GATA4 role in
the gonads. These partial and/or conditional Gata4 loss-of-
function models indicate that GATA4 is first required for normal
gonad development in both sexes and then later for the proper
function of the mature testis and the ovary [8,9,10,11,12].
Despite its pivotal role in gonadogenesis and many other
developmental processes, relatively little is known about the factors
and mechanisms that regulate Gata4 expression. Using a RACE
approach, we recently found that mouse, rat, and human GATA4
genes are expressed as multiple transcripts that differ in their
59origin owing to alternative usage of the first exon [13]. Two of
these non-coding first exons, exon 1a and exon 1b, are conserved
between species and are respectively located 3.5 and 31.5 kb
upstream of the Gata4 ORF start in exon 2. These two transcripts
(named E1a and E1b) were found to be co-expressed in all
GATA4-expressing tissues and both contribute to GATA4 protein
synthesis [13]. In addition to alternative transcripts, it is known
that transcriptional regulation of each Gata gene is complex, being
controlled by multiple tissue-specific enhancers [14]. In this
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expression in heart and liver was first identified in the zebrafish
[15]. In the mouse, analyses of conserved non-coding sequences
led to the identification of two distal enhancers located at 40 and
80 kb upstream of Gata4 E1a transcriptional start site and
sufficient to direct expression in the lateral mesoderm and a
subset of endoderm derivatives respectively [16,17]. The same
approach recently led to the identification of a complementary
endoderm enhancer located in intron 2 [18]. On the other hand,
we previously reported that a 5 kb fragment of rat Gata4 59
flanking sequences upstream of exon 1a is sufficient to direct
reporter gene expression to previously unappreciated Gata4
expression sites in a subset of cells from the inner cell mass of
pre-implantation embryos as well as a subset of migratory neural
crest cells [19]. Regarding gonadal expression, we also previously
reported that the same 5-kb fragment controls reporter gene
expression specifically in the testes and more precisely in Sertoli
cells from embryonic to adult stages [20,21]. A detailed analysis of
this 5-kb fragment revealed an evolutionary conserved Ebox
element (CACGTG) located near the transcriptional start site and
we found this regulatory element to be critical for Gata4 promoter
activity in vitro, being bound by USF2 in gonadal cell lines [20,22].
However, the importance of this Ebox motif in vivo is unknown.
Here we sought to determine the importance of the Ebox
element in the regulation of Gata4 expression in vivo by directly
mutating the endogenous motif by homologous recombination in
ES cells and derived mice containing the resulting Gata4
EboxKO
allele. Our data indicate that the Ebox motif is critical for the
specific expression of the E1a transcript in all examined tissues and
that the presence of E1b transcript can compensate the E1a loss
and ensure appropriate levels of GATA4 protein.
Materials and Methods
Ethics Statement
Experiments involving mice were performed following Canadi-
an Council of Animal Care (CCAC) guidelines for the care and
manipulation of animals used in medical research. Protocols
involving the manipulation of animals were approved by the
institutional ethics committee of the University of Quebec at
Montreal (comite ´ institutionnel de protection des animaux (CIPA);
Reference number 0511-R2-649-0512).
Gene Targeting and Generation of Gata4
EboxKO-Neo and
Gata4
EboxKO Mice
As depicted in Fig. 1A, the targeting construct was designed to
allow replacement of the endogenous Gata4 Ebox element
(CACGTG) by a HindIII restriction site (AAGCTT) and insertion
of a PGKp-Neomycin cassette flanked by LoxP sites (Floxed Neo) in
an 80 bp deletion in intron 1a-2. Sequences for the 59 (3.2 kb) and
39 (3.0 kb) homologous arms were obtained by PCR amplification
of FVB/n mouse genomic DNA using the Advantage II DNA
polymerase mix (Clontech). These PCR products were cloned into
the pGEM-T plasmid (Promega, Madison, WI) and sequences were
Figure 1. Targeting of the Ebox in the mouse Gata4 promoter upstream of exon 1a. (A) Schematic representation of the Gata4 locus,
targeting vector and final Cre-recombined Gata4
EboxKO allele. The targeting construct was designed to allow replacement of the Gata4 Ebox (white
circle) by a HindIII restriction site. A neomycin cassette flanked by LoxP sites (black triangles) was also included to allow G418-mediated selection in ES
cells. Black arrows indicate oligonucleotide primers and solid black bars indicate the location of the probes used for Southern blotting. H, HindIII; S,
SacI. (B) Southern blot analyses confirming the predicted targeting event on both the 59 and 39 side for an ES cell clone used to generate chimeras.
Genomic DNA was analyzed using the indicated combination of restriction endonuclease and probe. MW, 1 kb DNA ladder; ES, ES cell genomic DNA.
(C) PCR analysis of tail genomic DNA from F1 offspring using the primers 1 and 2 to amplify the wild-type allele and primers 1 and 3 to identify the
mutated allele.
doi:10.1371/journal.pone.0029038.g001
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recombination arm was then converted to a HindIII site using the
Quick Change Site-Directed Mutagenesis Kit according to the
manufacturer’s (Stratagene) instruction. The sequences of the
oligonucleotides used for amplification of the recombination arms
or site-directed mutagenesis are available upon request. The
targetingconstructwasfinalized bysubcloningoftherecombination
arms on each side of a Floxed Neo cassette to allow G418-mediated
selection in ES cells and subsequent Cre-mediated removal of the
cassette if needed. R1 ES cells (Sv129 genetic background) were
cultured on feeder cells under standard conditions as previously
described [19,23]. Cells were electroporated with 25 mgo f
linearized targeting vector and selected with G418 (225 mg/ml)
for 7 days. Surviving clones were isolated and homologous
recombination assessed by genomic Southern blot using HindIII
restriction endonuclease and hybridization with a probe from the 59
recombination arm as shown in Fig. 1B. Fidelity of the
recombination event was then confirmed with SacI restriction
endonuclease and a probe from the 39 recombination arm (Fig. 1B).
Microinjection of targeted ES cells into blastocysts and production
of chimeric mice was performed in accordance to standard
procedures [24] by the microinjection service of IRCM (Institut
de recherches cliniques de Montre ´al). These chimeras were then
mated with C57BL/6 females and heterozygous animals bearing
the Gata4
EboxKO-Neo allele were identified by Southern blot analysis as
described above. Gata4
+/EboxKO (Neocassette removed) animals were
obtained from a cross between Gata4
+/EboxKO-Neo and Meox2-Cre
(C57BL/6 genetic background; kindly provided by Dr Annik Prat,
IRCM) lines. Removal of the Neo cassette was confirmed by PCR.
Gata4
EboxKO-Neo and Gata4
EboxKO lines were maintained on a
mixed Sv129-C57BL/6 genetic background and genotyping of
both lines was performed by PCR using the following oligonucle-
otide primers:
N 1- Gata4-Fwd: 59-GGAAACTGGAGCTGGCCAGGTAG-39
N 2- Gata4-Rev: 59-CACCCATCAGTTTTTGCTGCTAATC-
39
N 3- LoxP-Rev: 59-TATACTAGAGCGGCCGGATCCAATC-
39
The wild-type allele was identified using primers 1 and 2
(234 bp) whereas the targeted allele was identified using primers 1
and 3 (169 bp) (Fig. 1A). For studies involving embryos, breeding
mice were mated overnight and noon of the day that a vaginal
plug was observed was designated as embryonic day (e) 0.5.
Tissue Collection and Processing for qPCR analyses
Gata4 expressing tissues (gonads, heart and liver) were collected
at different developmental stages (e15.5, postnatal day (P)14 and
adult mice) to assess expression of transcripts E1a and E1b by
qPCR. Total RNA was isolated from mouse tissues using TRIzol
reagent (Invitrogen, Burlington, Canada) in accordance to
manufacturer’s instruction. First strand cDNAs were synthesized
from a 0.5 to 5 mg aliquot of the various RNAs using the
Superscript II Reverse Transcriptase System (Invitrogen). Real
time qPCR was performed using a LightCycler 1.5 instrument and
the LightCycler FastStart DNA Master SYBR Green I kit (Roche
Diagnostics Canada, Laval, Canada) according to the manufac-
turer’s protocol. Primers used for qPCR are shown in Table 1. All
qPCR runs were done using the following conditions: 10 min at
95uC followed by 35 cycles of denaturation (5 sec at 95uC),
annealing (5 sec at 60uC), and extension (20 sec at 72uC) with a
single acquisition of fluorescence levels at the end of each
extension step. Each amplification was performed in duplicate
using at least three different preparations of first-strand cDNAs
prepared from each organ. The specificity of the amplified PCR
products was confirmed by analysis of the melting curve and
agarose gel electrophoresis. Differences in mRNA levels between
samples were quantified using the standard curve method. DNA
fragments containing E1a and E1b of the mouse Gata4 gene were
amplified by PCR and cloned into pGEM-T easy vector
(Promega) to generate the E1a and E1b standards for preparing
the dilution curves. A cloned fragment of the ribosomal gene Rpl19
served as reference gene. Serial dilutions of the target and
reference plasmids ranging from 0.1 fg/ml to 0.1 ng/ml were
prepared in order to generate the standard curves. The amount of
DNA for the target (E1a, E1b) and reference (Rpl19) in the
unknown samples was calculated by the LightCycler software 3.5
(Roche Diagnostics Canada) using the respective dilution curves.
Data are reported in arbitrary units as a ratio of the level of Gata4
E1a or E1b mRNA variant in each sample to that of the Rpl19
reference gene. For each time point, at least three animals per
genotype were analyzed.
Histological analyses and immunohistochemistry
For histological analyses, testes and ovaries were harvested at
the desired stage, fixed overnight in 4% paraformaldehyde and
embedded in paraffin. Paraffin sections (4 mm) were stained with
hematoxylin and eosin (H&E). Images were taken with a Leica
DFC 495 camera mounted on a Leica DM 2000 microscope
(Leica Microsystems Canada, Richmond Hill, Canada). For
immunohistochemistry, Paraffin-embedded sections were depar-
affinized, rehydrated, and treated with 10 mM citric acid in a
microwave oven for 10–20 min to improve antibody penetration.
Endogenous peroxidase activity was blocked with 3% hydrogen
peroxidase, and nonspecific binding was prevented by using 10%
horse serum. Sections were exposed overnight at 4uC to goat
polyclonal anti-mouse GATA4 IgG antibody (sc-1237X, Santa
Cruz Biotechnology, Santa Cruz, CA) diluted 1:500 in blocking
solution (PBS containing 0.1% BSA). Sections were counterstained
with hematoxylin and mounted with Permount (Sigma-Aldrich,
Oakville, Canada). For negative controls, primary antibody was
omitted. Slides were analyzed with a Zeiss Akioskop II
epifluorescence microscope (Carl Zeiss Canada, Toronto, Canada)
connected to a digital camera (Spot RT Slider; Diagnostic
Instruments, Sterling Heights, MI). For both histological and
immunohistochemistry analyses, three animals per genotype and
time point were examined.
Whole-mount immunohistochemistry
Whole-mount immunohistochemistry was performed on e9.5
embryos as previously described [24]. Briefly, embryos were first
collected in PBS and fixed in methanol: DMSO (4:1) overnight at
4uC. The embryos were then bleached in methanol: DMSO:
Table 1. Oligonucleotide primers used for qPCR.
Primer name Sequence
Gata4 E1a Forward 59-TCCGCGGACTCACGGAGATC-39
Gata4 E1b Forward 59-ACAGGCTGGAATCTCTGGGCCT-39
Gata4 E2 Reverse 59-ACCAGAGCGGCTCCAGCGAA-39
RpL19 Forward 59-CTGAAGGTCAAAGGGAATGTG-39
RpL19 Reverse 59-GGACAGAGTCTTGATGATCTC-39
doi:10.1371/journal.pone.0029038.t001
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through 50% methanol, and finally PBS. Embryos were incubated
twice in PBSMT (2% instant skim milk powder, 0.1% Triton X-
100 in PBS) for 1 hr at room temperature, then with primary
antibody goat anti-mouse GATA4 antibody (sc-1237X, Santa
Cruz Biotechnology, CA, USA) diluted in PBSMT (1:50) at 4uC
overnight. Embryos were washed twice in PBSMT at 4uC and 3
times at room temperature for 1 hr each, followed by an overnight
incubation at 4uC with horseradish peroxidase-conjugated rabbit
anti-goat IgG (Santa Cruz Biotechnology, CA, USA) diluted in
PBSMT (1:500). Embryos were washed as described above with an
additional final 20-min wash in PBT (0.2% BSA, 0.1% Triton X-
100 in PBS) at room temperature. For the color reaction, embryos
were pre-incubated with 0.3 mg/ml of 3, 30-diaminobenzidine
tetrahydrochloride (Sigma-Aldrich) in PBT for 30 min at room
temperature, followed by addition of H2O2 to 0.0003% and
incubation at room temperature until a brown color develops.
Embryos were then rinsed in PBT to stop the reaction, post-fixed
overnight in 4% paraformaldehyde and cleared in glycerol:PBS
(1:1). Images were taken with a Leica DFC 495 camera mounted
on a Leica M205 FA stereomicroscope (Leica Microsystems
Canada).
Statistical analysis
Comparisons of E1a and E1b transcript levels between wild-
type and Gata4
EboxKO/ EboxKO tissues (Figs. 2 and 3) were analyzed
using Student’s t-test; P , 0.05 was considered significant. All
statistical analyses were done using SigmaStat 3.5 software (Systat
Software Inc., San Jose, CA).
Results
Targeted mutation of the endogenous Gata4 Ebox
element
Our previous analysis of the proximal 59 sequences upstream of
Gata4 exon 1a, using luciferase assays and site-directed mutagen-
esis, demonstrated that an Ebox element is essential for promoter
activity in several Gata4-expressing cell lines [20]. To confirm the
importance of this motif in vivo, we generated a novel Gata4 mutant
allele in which the endogenous Ebox element (CACGTG) was
replaced by a HindIII restriction site using homologous recombi-
nation in ES cells (Fig. 1A). The resulting allele containing the
mutated Ebox was first designated Gata4
EboxKO-Neo because of the
persistence of a neomycin selection cassette flanked by LoxP sites
(Floxed Neo) in intronic sequences between exon 1a and 2.
Chimeras generated from Gata4
+/EboxKO-Neo ES cells gave germline
transmission and Gata4
+/EboxKO-Neo animals were viable and fertile.
To confirm that the novel mutated motif is devoid of activity, we
tested its functionality using an electrophoretic mobility shift assay
(EMSA). In contrast to a wild-type probe, a probe bearing the
mutated (HindIII) motif failed to compete the binding of USF1/2
proteins, demonstrating that the mutated element is indeed
inactive (Fig. S1).
The presence of a Neo selection cassette in intron 1a-2
leads to severe loss of GATA4 expression
Intercrosses of Gata4
+/EboxKO-Neo animals were established but
failed to produce viable homozygous offspring, suggesting
embryonic lethality. Embryos from these matings were thus
collected at e9.5, corresponding to the oldest stage at which non-
resorbing Gata4-null embryos can be obtained [5,6]. This analysis
revealed that homozygous Gata4
EboxKO-Neo embryos represented
only 13.6% (32/233) of the total genotyped embryos. We also
found that these homozygous Gata4
EboxKO-Neo embryos displayed
ventral morphology defects as well as an abnormal heart tube (Fig.
S2A, B). Such non-mendelian ratio and morphogenesis defects are
reminiscent of those previously reported in Gata4-nulls [5,6] and
suggest severe loss of GATA4 protein. In accordance with this,
whole-mount immunohistochemistry revealed a drastic reduction
of GATA4 protein levels in Gata4
EboxKO-Neo/EboxKO-Neo e9.5 embryos
(Fig. S2C, D).
To determine if this phenotype was due to the Ebox mutation or
the insertion of the Neo cassette, we crossed Gata4
+/EboxKO-Neo mice
with Meox2-Cre mice [25] expressing the Cre recombinase in the
epiblast in order to remove the floxed Neo cassette in all
Figure 2. Comparison of gonadal E1a and E1b transcript levels
between wild-type (WT) and Gata4
EboxKO / EboxKO mutant
animals. Quantitative PCR was used to assess Gata4 E1a and E1b
mRNA levels in mouse gonads at e15.5 (A), P14 (B) and adult (C) stages.
Data are reported in arbitrary units as a ratio of the level of Gata4 E1a or
E1b mRNA variant to that of the Rpl19 reference gene. N indicates the
number of animals examined.
doi:10.1371/journal.pone.0029038.g002
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homozygous Gata4
EboxKO mice did not display any obvious
phenotype or altered sex ratios and were fertile (see Table 2).
Thus, this indicates that the presence of the Neo cassette is
responsible of the lethal phenotype of Gata4
EboxKO-Neo/EboxKO-Neo
embryos.
The Ebox motif is a specific and critical regulatory
element of Gata4 E1a transcription in vivo
We have previously reported that Gata4 is expressed as multiple
transcripts with different 59 ends encoded by alternative
untranslated first exons and that two of these transcripts, E1a
and E1b, are co-expressed in GATA4-expressing tissues from
different species [13]. Therefore, to verify the impact of the Ebox
mutation on Gata4 expression, expression of transcripts E1a and
E1b was assessed by qPCR in different tissues (gonads, heart and
liver) and at different developmental stages (e15.5, P14 and adult).
In the gonads, this analysis first revealed sex- and stage-
dependent differences in relative expression levels of each
transcript in wild-type tissues. In the testis, transcript E1a is
preferentially expressed at e15.5 (Fig. 2A) and then the level of
each transcript becomes similar at the two week-old and adult
stages (Fig. 2B, C). In the ovary, an inverted profile was observed
with comparable expression levels of each transcript at e15.5
(Fig. 2A) followed by predominance of E1a transcript at the two
week-old and adult stages (Fig. 2B, C). Interestingly, our data
further indicate that, in homozygous Gata4
EboxKO animals, a
robust decrease of E1a transcript expression is observed in a sex-
and stage-independent manner while E1b transcript expression
Figure 3. Comparison of extra-gonadal E1a and E1b transcript levels between wild-type (WT) and Gata4
EboxKO/ EboxKO mutant
animals. Quantitative PCR was used to assess Gata4 E1a and E1b mRNA levels in the heart (A–C) and liver (D–F) at e15.5 (A, D), P14 (B, E) and adult
(C, F) stages. Data are reported in arbitrary units as a ratio of the level of Gata4 E1a or E1b mRNA variant to that of the Rpl19 reference gene. N
indicates the number of animals examined.
doi:10.1371/journal.pone.0029038.g003
Table 2. Fertility tests for Gata4
EboxKO/EboxKO mice.
Fertility Parameter WT Mutant
Breeding rate* 36.4% (12/33) 42% (13/31)
Pregnancy rate** 58.3% (7/12) 53.9% (7/13)
Average number of pups per litter 6.4 7
*Number of plugged females per total number of breeding females.
**Number of pregnant females per total number of plugged females.
doi:10.1371/journal.pone.0029038.t002
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embryonic gonads (89%) (Fig. 2A) rather than at the two week-old
and adult stages (80% and 70% respectively) (Fig. 2B, C). Of note,
this analysis also revealed a slight but significant increase of E1b
transcript levels in embryonic testes (Fig. 2A).
In extra-gonadal tissues, stage-dependent differences in relative
expression levels of each transcript were also observed in wild-type
tissues. In the heart, E1a transcript is predominantly expressed in
embryos while E1b transcript is predominant in adult heart
(Fig. 3A, C) and both transcripts are similarly expressed in two
week-old animals (Fig. 3B). In the liver, E1a transcript is
predominantly expressed in embryonic and adult tissues (Fig. 3D,
F) while expression of the E1b transcript is predominant in two
week-old animals (Fig. 3E). Again, in homozygous Gata4
EboxKO
animals, an important decrease of E1a transcript expression was
observed in both the heart and liver. Much like the fetal testis
(Fig. 2A), a slight but significant increase of E1b transcript was also
specifically observed at the embryonic stage in heart and liver
(Fig. 3A, D).
Taken together, these data clearly indicate that the Ebox
element just upstream of Gata4 exon 1a, is a key and specific
regulatory element of in vivo Gata4 E1a transcript expression in
multiple GATA4-expressing tissues throughout development.
A severe reduction of Gata4 E1a transcript expression is
not associated with an overt gonadal phenotype
To assess the impact of E1a transcript reduction on gonad
morphology, hematoxylin and eosin stained transverse sections of
testes (Fig. S3) and ovaries (Fig. S4) were prepared from wild-type
and homozygous Gata4
EboxKO mice at the same developmental
stages than those used for the qPCR analysis. This analysis
revealed that Gata4
EboxKO/EboxKO gonads from all stages do not
display any gross histological defects. Although it was quite
unexpected given the order of reduction of E1a transcript levels,
such an outcome suggested that GATA4 protein levels were not
significantly affected in Gata4
EboxKO/EboxKO gonads. To verify this,
GATA4 immunohistochemistry was performed on paraffin
sections of wild-type and Gata4
EboxKO/EboxKO gonads obtained at
the same developmental stages. As shown in Figs. 4 and 5, and in
accordance with a lack of gonadal phenotype, there was no
obvious reduction of GATA4 protein levels in the mutant gonads.
For both genotypes, GATA4 is strongly expressed in somatic cells
Figure 4. Analysis of endogenous GATA4 protein in Gata4
EboxKO/ EboxKO mutant testes. GATA4 immunohistochemistry was performed on
paraffin testis sections obtained from E15.5 embryos (A, B), two week-old (C, D) and adult mice (E, F). At each stage, note that no obvious differences
in GATA4 protein levels are found between the wild-type (WT) and mutant testis. Arrowheads indicate the characteristic intense staining usually
detected in Sertoli cells nuclei. Insets: control= no primary antibody. Images were taken at 200x magnification. TC, testis cord; ST, seminiferous
tubule.
doi:10.1371/journal.pone.0029038.g004
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old (Fig. 4C–D, Fig. 5C–D) and adult (Fig. 4E–F, Fig. 5E–F)
stages.
On the other hand, we also hypothesized that a subtle change in
GATA4 protein levels might have been missed by immunohisto-
chemistry. To verify this possibility, we bred homozygous
Gata4
EboxKO mice with either Gata4
+/EboxKO-Neo or Gata4
+/- animals
and analyzed the resulting Gata4
EboxKO/EboxKO-Neo and Gata4
EboxKO/-
mice. This analysis revealed that, in both cases, animals appeared
normal and were fertile (data not shown). Thus, even in
combination with the null allele (50% reduction of GATA4
protein), the presence of the EboxKO allele does not lead to a
functional drop in GATA4 protein levels.
Discussion
The gene targeting approach used in this study led to the
generation of a novel and unexpected severe hypomorphic Gata4
allele. Indeed, we found that animals homozygous for the
Gata4
EboxKO-Neo allele, which retained the floxed PGKp-Neo
selection cassette in intron 1a-2, recapitulate the Gata4-null
phenotype and die around e9.5. Using Cre-mediated excision,
we demonstrated that this phenotype is caused by the sole
presence of the Neo cassette. There are several possible
explanations for this outcome. The presence of these exogenous
PGKp-Neo sequences might result in a general decrease in the
total number of GATA4-encoding transcripts because of promoter
competition from the PGKp sequences, abnormal splicing of exon
2 or defective intronic regulatory sequences. In support of the
later, it is known that Gata tissue specific expression can be
regulated via transcriptional enhancers located in introns [14] and
a functional Gata4 transcriptional enhancer has been recently
identified in intron 2 [18]. However, the fact that a LoxP site still
remains in the Gata4
EboxKO allele following Cre-mediated recom-
bination rules out the possibility that the phenotype might have
been due to the fortuitously insertional disruption of a key Gata4
regulatory element. On the other hand, we cannot rule out the
possibility that insertion of the 3 kb Neo cassette might have
isolated some regulatory elements crucial for expression of most of
the Gata4 mRNA variants. Taking this possibility into account, our
targeting procedure led to the insertion of the Neo cassette in an
80 pb deletion in order to compensate for the final insertion of the
LoxP site and surrounding plasmid sequences following Cre-
mediated excision of the cassette; this strategy allowed preserving
the exact same original spacing following Cre-mediated recombi-
nation. Irrespective of the exact hypomorphic mechanism, this
Figure 5. Analysis of endogenous GATA4 protein in Gata4
EboxKO/ EboxKO mutant ovaries. GATA4 immunohistochemistry was performed on
paraffin ovary sections obtained from E15.5 embryos (A, B), two week-old (C, D) and adult mice (E, F). At each stage, note that no obvious differences
are found between the wild-type (WT) and mutant ovary. Arrowheads indicate the characteristic intense staining usually detected in granulosa cell
nuclei. Insets: control= no primary antibody. Images were taken at 200x magnification. O, ovary; M, mesonephros, F, follicle.
doi:10.1371/journal.pone.0029038.g005
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EboxKO-Neo allele represents an interesting genetic tool
for dissection of GATA4 functions if used in a setting allowing
appropriate rescue of the ventral defects. Given that such defects
in Gata4-nulls are caused by defective visceral endoderm, the
Transthyretin-Cre mouse would represent a good model to use for
rescue purposes [26,27].
Although the mutation of the Ebox motif leads to a robust
decrease of E1a transcript expression (between 70 and 89%), both
tissue morphology and GATA4 protein levels appeared surpris-
ingly unaffected in homozygous Gata4
EboxKO gonads. This indicates
that the Gata4 E1b transcript variant, for which expression levels
were either unaffected or slightly increased in homozygous
Gata4
EboxKO mutant tissues, is sufficient to ensure appropriate
production of a normal and functional GATA4 protein. Such
outcome is in total accordance with our prior work, where we
showed by polysome analysis that both Gata4 E1a and E1b
transcripts are actively translated in mouse testes [13]. This
observation also raises the intriguing possibility that, at least under
certain circumstances, each transcript might be translated with
different efficiency. In this regard, it is interesting to note that,
among the several different ways by which translation can be
regulated, the secondary structure of the 59 UTR is known to have
a profound influence on translation efficiency [28]. Indeed, it has
been previously shown that loose structures at the 59 end promotes
whereas tight structures inhibits translation [29,30]. In support of
such a model for translation of the Gata4 transcripts, E1a and E1b
mRNAs precisely differ only by the extremity of their 59 UTR and
this appears to be enough for generating mRNA variants with
different predicted secondary structures [13]. Further investiga-
tions will ultimately be required in order to understand this
potential difference in transcript translation. For example, it would
be particularly interesting to determine if E1b transcripts always
exhibit preferential translation over the E1a variant or if this
happens only when E1a levels are reduced.
In conclusion, this work clearly demonstrates that the Ebox
motif of the proximal Gata4 promoter is a key regulatory element
of Gata4 E1a transcript expression in vivo. More surprisingly, this
work also underscored the fact that, even in the near absence of
E1a transcripts, E1b transcripts can compensate and allow
maintenance of normal and functional GATA4 protein levels.
Considering the critical importance of GATA4 for the develop-
ment and function of many organs, such a buffer mechanism is not
altogether surprising.
Supporting Information
Figure S1 A mutated Ebox motif does not bind USF1/2
proteins. Recombinant USF1 and USF2 proteins efficiently bind
to a labeled probe containing the Ebox motif present in promoter
sequences just upstream of exon 1a. Binding of USF1 and USF2
protein was competed by unlabeled wild-type probe (self) but not a
probe containing the mutation (mut) used to generate the
Gata4
EboxKO allele.
(TIF)
Figure S2 Embryonic lethality of homozygous
Gata4
EboxKO-Neo animals. (A, B) In comparison to wild-type
(A) littermates, surviving e9.5 Gata4
EboxKO-Neo/EboxKO-Neo em-
bryos (B) exhibit delayed development and severe ventral defects
characterized by defective rostral-to-caudal and lateral-to-
ventral folding as well as an abnormal heart tube. (C, D)
Whole-mount immunohistochemistry on wild-type (C) and
Gata4
EboxKO-Neo/EboxKO-Neo (D) e9.5 embryos showing a drastic
decrease of GATA4 protein in the mutants. Note that for
immunohistochemistry, all age-matched embryos were processed
and stained in parallel. Pictures were taken at 16X magnification.
(TIF)
Figure S3 Histological analysis of Gata4
EboxKO/EboxKO
mutant testes. Serial hematoxylin-and-eosin-stained transverse
sections of testes obtained from the indicated developmental stages
showing no significant histological differences between wild-type
(WT) and mutant tissues. Images were taken at 100x magnifica-
tion. TC, testis cord; ST, seminiferous tubule.
(TIF)
Figure S4 Histological analysis of Gata4
EboxKO/EboxKO
mutant ovaries. Serial hematoxylin-and-eosin-stained trans-
verse sections of ovaries obtained from the indicated developmen-
tal stages showing no significant histological differences between
wild-type (WT) and mutant tissues. Images were taken at 100x
magnification. O, ovary; M, mesonephros, F, follicle.
(TIF)
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